Compare KVYO & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KVYO | STVN |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | | Containers/Packaging |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 7.4B |
| IPO Year | 2023 | 2021 |
| Metric | KVYO | STVN |
|---|---|---|
| Price | $32.01 | $20.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 4 |
| Target Price | ★ $43.54 | $25.38 |
| AVG Volume (30 Days) | ★ 2.2M | 281.8K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.31% |
| EPS Growth | N/A | ★ 19.61 |
| EPS | N/A | ★ 0.60 |
| Revenue | $1,153,988,000.00 | ★ $1,373,219,524.00 |
| Revenue This Year | $32.38 | $8.42 |
| Revenue Next Year | $21.60 | $9.52 |
| P/E Ratio | ★ N/A | $34.35 |
| Revenue Growth | ★ 32.81 | 6.97 |
| 52 Week Low | $23.44 | $17.81 |
| 52 Week High | $49.55 | $28.00 |
| Indicator | KVYO | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 66.13 | 39.35 |
| Support Level | $28.55 | $20.50 |
| Resistance Level | $30.35 | $21.54 |
| Average True Range (ATR) | 1.14 | 1.06 |
| MACD | 0.20 | -0.06 |
| Stochastic Oscillator | 94.59 | 11.29 |
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.